HIGH-DOSE THERAPY AND RISK OF MALPRACTICE SUIT - REPLY

被引：0

|

作者：

DIAMOND, S

机构：

来源：

POSTGRADUATE MEDICINE | 1987年 / 82卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：34 / 34

页数：1

相关论文

共 50 条

[1] Risk Associated With High-Dose Bicalutamide Reply
Stein, Mark N.
Jang, Thomas L.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
[2] COMBINED MODALITY THERAPY IN HIGH-DOSE RADIONEUROSURGERY - REPLY
FLENTJE, M
ENGENHART, R
[J]. RADIOTHERAPY AND ONCOLOGY, 1993, 26 (02) : 181 - 182
[3] High-dose chemotherapy in high-risk breast cancer - Reply
Pusztai, L
Hortobagyi, GN
[J]. LANCET, 1998, 352 (9139): : 1552 - 1552
[4] High-dose statin therapy for high-risk patients
Saely, C. H.
Drexel, H.
Huber, K.
[J]. HERZ, 2010, 35 (07) : 497 - 502
[5] HIGH-DOSE NEUROLEPTICS - REPLY
KRAKOWSKI, M
KUNZ, M
CZOBOR, P
VOLAVKA, J
[J]. HOSPITAL AND COMMUNITY PSYCHIATRY, 1994, 45 (07): : 722 - 722
[6] HIGH-DOSE MORPHINE - REPLY
WARFIELD, CA
[J]. HOSPITAL PRACTICE, 1984, 19 (12): : 23 - 23
[7] High-Dose Intravenous Vancomycin Therapy and the Risk of Nephrotoxicity
Rostas, Sara E.
Kubiak, David W.
Calderwood, Michael S.
[J]. CLINICAL THERAPEUTICS, 2014, 36 (07) : 1098 - 1101
[8] Adjuvant high-dose interferon therapy for high-risk melanoma
Ready, N
Weinstock, MA
[J]. ARCHIVES OF DERMATOLOGY, 2003, 139 (12) : 1635 - 1637
[9] HIGH-DOSE CYTOSINE-ARABINOSIDE THERAPY FOR REFRACTORY LEUKEMIA - REPLY
HERZIG, GP
[J]. BLOOD, 1984, 64 (03) : 759 - 759
[10] COAGULATION PARAMETERS IN HIGH-DOSE INTRAVENOUS HEPARIN-THERAPY - REPLY
HAFNER, G
[J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1994, 119 (12) : 442 - 442

← 1 2 3 4 5 →